Takeda appoints Rhonda Pacheco President of US Business Unit
Rhonda Pacheco to succeed Julie Kim, who was appointed to be Takeda’s next CEO
Rhonda Pacheco to succeed Julie Kim, who was appointed to be Takeda’s next CEO
Hemant Surgical Industries receives order
CRISPR-based detection enables highly specific molecular recognition
Four FDA-approved products strengthen portfolio and reaffirm commitment to global reach
Sun Pharma's Halol plant gets OAI classification from US FDA inspection
The Ma’anshan site approval covers pastilles, oral liquids, and powders
The facility has been designed with a dual focus on efficiency and sustainability
New Bay Area building marks significant progress as part of $32 billion US investment projected to create $43 billion in economic value
Subscribe To Our Newsletter & Stay Updated